This inventor holds 27 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in RNA Modulation. Top assignees: Ptc Therapeutics, Inc., F. Hoffmann-La Roche Ag, Hoffmann-La Roche Inc.. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- East Brunswick, NJ (US) (2012 - 2023)
- South Plainfield, NJ (US) (2018 - 2023)
Company Filing History:
27 out of 186 
6 out of 181 
4 out of 5,026 
Years Active: 2012-2025
Areas of Expertise:
Title: The Innovations of Nikolai A. Naryshkin in Spinal Muscular Atrophy Treatment
Introduction
Nikolai A. Naryshkin, a prominent inventor based in South Plainfield, NJ, has made significant contributions to the field of pharmacology, specifically in the development of treatments for spinal muscular atrophy. With an impressive portfolio of 25 patents, Naryshkin's work showcases his commitment to advancing medical science and improving patient outcomes.
Latest Patents
Naryshkin's recent patents, particularly focusing on compounds for treating spinal muscular atrophy, are revolutionizing the therapeutic landscape. His latest inventions provide compounds of formula (I), offering innovative solutions for treating this debilitating condition. These compositions are designed for enhanced efficacy and are aimed at providing new hope to patients battling spinal muscular atrophy.
Career Highlights
Throughout his career, Naryshkin has collaborated with some of the leading companies in the pharmaceutical industry. Notably, he has worked with PTC Therapeutics, Inc. and F. Hoffmann-La Roche AG. His dedication to research and innovation has facilitated groundbreaking advancements in drug development, significantly impacting the lives of patients and the medical community.
Collaborations
Naryshkin has had the pleasure of working alongside esteemed colleagues such as Ellen Welch and Amal Dakka. These collaborations have enriched his research endeavors and contributed to the collective goal of developing effective therapies for challenging medical conditions. The synergy between Naryshkin and his coworkers reflects a commitment to teamwork and excellence in the pursuit of scientific innovation.
Conclusion
Nikolai A. Naryshkin exemplifies the spirit of innovation in the medical field through his extensive portfolio of patents and collaborative efforts. His groundbreaking work on spinal muscular atrophy treatments not only highlights his prowess as an inventor but also underscores the importance of research in advancing healthcare. As he continues to innovate, Naryshkin remains a notable figure in the landscape of pharmaceutical inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile